Opendata, web and dolomites


Commercialisation of Advanced Extrusion Technologies through Materials Innovation to Enhance the Performance Functionality of Catheter Based Medical Devices

Total Cost €


EC-Contrib. €






 ExtruLub project word cloud

Explore the words cloud of the ExtruLub project. It provides you a very rough idea of what is the project "ExtruLub" about.

26    mncs    polymer    batch    friction    extrusion    commands    latter    antithrombogenic    safeguards    savings    enhancement    safety    share    utilise    realising    drive    medtech    sub    functional    markets    resins    564    reduce    employed    2020    companies    supply    links    initial    expanding    cardiology    business    antimicrobial    market    catheters    successful    mn    surfaces    surface    direct    manufacturing    independent    scientific    export    extrulubtm    passing    industry    engaging    generate    oem    medtronic    members    diania    boston    revenues    containment    genuine    manufacturer    global    dnt    ca    perspective    patient    positive    reaching    team    42    device    lean    catheter    innovative    employees    subsupply    benefits    technologies    optimisation    applicable    51    profile    board    38    economic    protective    commercialisation    led    fits    differentiation    disruptive    facilitates    globally    showed    bn    core    rollout   

Project "ExtruLub" data sheet

The following table provides information about the project.


Organization address
city: Galway
postcode: H91 Y682
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Total cost 2˙501˙602 €
 EC max contribution 1˙746˙484 € (70%)
 Programme 1. H2020-EU.2.1.5. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing)
2. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-2-2016-2017
 Funding Scheme SME-2
 Starting year 2017
 Duration (year-month-day) from 2017-09-01   to  2020-02-29


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DIANIA TECHNOLOGIES LIMITED IE (Galway) coordinator 1˙746˙484.00


 Project objective

ExtruLubTM is an innovative, disruptive extrusion technology applicable across a range of polymer resins, which can change the surface of a catheter without affecting core device properties. The technology fits in the component sub-supply market with an initial global market of €564 mn applicable across all catheter markets, the latter estimated to reach $42.5 bn globally by 2020. From a functional perspective, it has the ability to reduce surface friction, generate protective antimicrobial & antithrombogenic surfaces, passing these benefits and profile reduction to catheters. This functional enhancement safeguards patient safety & commands genuine product differentiation for the device manufacturer, enabling market share. From an economic perspective it facilitates a change from lean to batch manufacturing realising cost containment. For example, an independent study showed ExtruLubTM, employed in the cardiology sector, would reduce costs for the OEM (e.g. Boston Scientific, Medtronic etc.) by 51 %, realising savings for them of ca. €3 mn p.a in one product. DiaNia Technologies will drive the optimisation & advancement of successful Phase 1 results through to commercialisation of ExtruLubTM into selected devices, engaging with a number of successful, leading MedTech companies. In doing so we will utilise direct links with MNCs at the early development phase of their new products. DNT will be taking an export led approach, exploiting the experience of our business development team & board members in expanding our component subsupply business in the MedTech industry. The positive effects of this project include increase in revenues to over €26 MN & employees numbers reaching 38 in YR 5 through the successful rollout of ExtruLubTM Technology.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EXTRULUB" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EXTRULUB" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.5.;H2020-EU.2.1.3.;H2020-EU.2.3.1.;H2020-EU.2.1.2.)


Super Productive Line Printing Inkjet

Read More  

HelpingHAND (2018)

A 3D printed, affordable myoelectrical prosthetic hand of personalizeable size for optimal comfort and functionality

Read More  

Volumizer (2018)

A natural, non-surgical, and safe facial filler which treats the root cause of facial ageing.

Read More